Brought to you by 
Medtronic helps develop Scil's rhGDF-5
09 Feb 2011
Executive Summary
Medtronic and biomaterials developer Scil Technology GMBH have signed an agreement for Scil's biologic recombinant human growth and differentiating factor-5 (rhGDF-5).
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Biomaterials
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com